WaveMan
WaveMan · Company
RBOT · Vicarious Surgical Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

RBOT Vicarious Surgical (RBOT) Insider Trading, Ownership & Congress Trades

Medical Devices · Orthopedic, prosthetic & surgical appliances & supplies · CIK 0001812173
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
1
13F, latest reported quarter

Vicarious Surgical insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Vicarious Surgical Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Sachs Adam David
President
SELL
2026-02-24 SECtraded 2026-02-20
942
$2.0K
-99.0%
Context
  • 55 earlier Form 4 trades (code P or S) here by this insider (55 sales), the last on Dec 3, 2025.
  • The trade is 2.0% of the 46,943 shares held after it.
  • 1 other insider sold within 30 days.
  • 1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: President Sachs Adam David sold about $2.0K of RBOT on Feb 20, 2026; 1 other insider sold within 30 days and 1 fund added in the latest 13F quarter.
Khalifa Sammy
Chief Technology Officer
SELL
2026-02-24 SECtraded 2026-02-20
754
$1.6K
-99.0%
Context
  • 54 earlier Form 4 trades (code P or S) here by this insider (54 sales), the last on Dec 3, 2025.
  • The trade is 2.3% of the 32,869 shares held after it.
  • 1 other insider sold within 30 days.
  • 1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Khalifa Sammy sold about $1.6K of RBOT on Feb 20, 2026; 1 other insider sold within 30 days and 1 fund added in the latest 13F quarter.
Sachs Adam David
President
SELL
2025-12-04 SECtraded 2025-12-03
463
$1.4K
-99.3%
Context
  • 54 earlier Form 4 trades (code P or S) here by this insider (54 sales), the last on Nov 20, 2025.
  • The trade is 1.0% of the 47,885 shares held after it.
  • 1 other insider sold within 30 days.
  • 1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: President Sachs Adam David sold about $1.4K of RBOT on Dec 3, 2025; 1 other insider sold within 30 days and 1 fund added in the latest 13F quarter.
Khalifa Sammy
Chief Technology Officer
SELL
2025-12-04 SECtraded 2025-12-03
239
$710
-99.3%
Context
  • 53 earlier Form 4 trades (code P or S) here by this insider (53 sales), the last on Nov 20, 2025.
  • The trade is 0.7% of the 33,623 shares held after it.
  • 1 other insider sold within 30 days.
  • 1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Khalifa Sammy sold about $710 of RBOT on Dec 3, 2025; 1 other insider sold within 30 days and 1 fund added in the latest 13F quarter.
Khalifa Sammy
Chief Technology Officer
SELL
2025-11-21 SECtraded 2025-11-20
653
$1.8K
-99.2%
Context
  • 52 earlier Form 4 trades (code P or S) here by this insider (52 sales), the last on Sep 3, 2025.
  • The trade is 1.9% of the 33,862 shares held after it.
  • 1 other insider sold within 30 days.
  • 1 fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Khalifa Sammy sold about $1.8K of RBOT on Nov 20, 2025; 1 other insider sold within 30 days and 1 fund added in the latest 13F quarter.
237 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 232 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
1 fund bought in last quarter
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
4.2% of the float short (float per yahoo 2026-10-26) · 1.1 days to cover · settled 2026-09-30
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch RBOT

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-99.7%12M
-100%-67%-33%+0%2025-102025-122026-022026-042026-062026-08 2025-11-20 · Sachs Adam David sold $2.2K2026-02-20 · Sachs Adam David sold $2.0K2025-11-20 · Khalifa Sammy sold $1.8K2026-02-20 · Khalifa Sammy sold $1.6K2025-12-03 · Sachs Adam David sold $1.4K2025-12-03 · Khalifa Sammy sold $710
Insider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns RBOT: institutional holders (13F)

13F holdings, latest reported quarter
K5 Global Advisor LLC
720 sh
$5.0K

Congress trades in RBOT

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

RBOT planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 1 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

RBOT financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
0.36x
long-term 2023-12-31 (24 months older than the period end) plus current 2021-03-31 (57 months older than the period end); equity 2025-12-31
Cash flow to debt
-12.88x
TTM operating cash flow over long-term 2023-12-31 (24 months older than the period end) plus current 2021-03-31 (57 months older than the period end)
Return on equity
-177.5%
TTM net income over average of 2024-12-31 and 2025-12-31
Return on assets
-115.0%
TTM net income over average of 2024-12-31 and 2025-12-31
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-132.1%
operating income (EBIT proxy) over average of 2024-12-31 and 2025-12-31 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
n/a
no share count filed
FCF yield
n/a
no share count filed
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Operating income-$50.0M-$66.6M-$80.7M-$80.1M
Net income-$50.2M-$63.2M-$71.1M$5.2M
EPS (diluted)n/an/a-0.490.04
Operating cash flow-$45.1M-$50.0M-$62.3M-$61.2M
Cash$2.6M$9.7M$52.8M$116.2M
Long-term debtn/an/a$2.0Mn/a
SEC XBRL, fiscal years, as known on 2026-10-28

RBOT Stock Sonar score 3/7 axes

Find similar shapesCompare

RBOT ranks highest on risk and compliance (53rd percentile) and financial health (28th), and lowest on profitability (15th), among Medical Devices peers.

Profitability
15
Inputs
  • Return on equity-177.5% · 15 pct, sector of 183
  • Return on assets-115.0% · 16 pct, sector of 214
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-132.1% · 13 pct, sector of 188
Financial health
28
Inputs
  • Debt to equity0.36x · 45 pct, sector of 159
  • Cash flow to debt-12.88x · 11 pct, sector of 150
Risk and compliance
53
Inputs
  • Short interest, % of float+4.2% · 53 pct, sector of 240
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Growth, Insider conviction, Institutional and government, US patents
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies